Extranasopharyngeal angiofibroma of the sinonasal tract: A systematic review
European Archives of Oto-Rhino-Laryngology · 2026
DOI: 10.1007/s00405-025-09985-7 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2026. Verfasst von Fabio Portella Gazmenga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, University of Campinas, Campinas, Brazil. fgazmenga@gmail.com. Hauptthemen laut MEDLINE: Angiofibroma, Paranasal Sinus Neoplasms. Die Arbeit nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Estadual De Campinas.
Abstract (Originalsprache)
Purpose
Extranasopharyngeal angiofibromas of the sinonasal tract (ENA-SNT) are exceptionally rare tumors that remain poorly characterized in the literature. We aim to systematically review and synthesize the clinical characteristics, management, and outcomes of ENA-SNT.
Methods
This review adhered to PRISMA guidelines. A literature search was conducted across major databases, including PubMed, EMBASE, Web of Science, and Google Scholar. Articles that reported ENA-SNT cases in humans were eligible for inclusion. Data extraction and quality assessment were independently performed by two reviewers.
Results
A total of 145 studies were included, comprising 163 patients. The mean age was 28.8 years (range, 0–78), with a male-to-female ratio of 2.1:1. The nasal septum (33.3%), inferior turbinate (16.6%), and maxillary sinus (16.0%) were the most frequent tumor sites. Common symptoms included nasal obstruction (73.0%) and epistaxis (68.1%), often in combination (55.2%). Angiography demonstrated no hypervascularity in 23.1% of cases; when present, the internal maxillary artery supplied the tumor in 96.1%. Preoperative biopsy caused brisk bleeding in 44.5%. Surgery was the primary treatment in 94.4% of cases, with a recurrence rate of 5.3% and an average time to recurrence of 3.8 months. Intracranial and orbital involvement were rare: 1.84% and 2.45%, respectively.
Conclusion
This review supports ENA-SNT as a clinical entity distinct from juvenile nasopharyngeal angiofibroma. Symptoms develop more rapidly, but the tumor is less aggressive, less vascularized, and has a better prognosis. ENA-SNT can occur across all age groups and in female individuals. Surgical resection is the treatment of choice, with low recurrence rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology, Head and Neck Surgery, University of Campinas, Campinas, Brazil. fgazmenga@gmail.com.
- Department of Otorhinolaryngology, Plastic Head & Neck Surgery, Kliniken Maria Hilf Mönchengladbach, Mönchengladbach, Germany.
- Department of Otolaryngology, Head and Neck Surgery, University of Campinas, Campinas, Brazil.
Förderung
- Universidade Estadual De Campinas
Zitieren
APA
Gazmenga, F. P., Windfuhr, J. P., Lau, F., Toro, M. D. C., & Sakano, E. (2026). Extranasopharyngeal angiofibroma of the sinonasal tract: A systematic review. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-025-09985-7
Vancouver
Gazmenga FP, Windfuhr JP, Lau F, Toro MDC, Sakano E. Extranasopharyngeal angiofibroma of the sinonasal tract: A systematic review. European Archives of Oto-Rhino-Laryngology. 2026. doi:10.1007/s00405-025-09985-7
BibTeX
@article{Gazmenga2026,
author = {Gazmenga, Fabio Portella and Windfuhr, Jochen P and Lau, Fabio and Toro, Mariana D C and Sakano, Eulalia},
title = {Extranasopharyngeal angiofibroma of the sinonasal tract: A systematic review},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2026},
doi = {10.1007/s00405-025-09985-7}
}
EUVIMED